Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
<h4>Background</h4>Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements in cure rates, prediction of disease outcome remains a major challenge and survivors suffer from serious therapy-related side-effects. Recent data showed that patients wit...
Guardado en:
Autores principales: | Marcel Kool, Jan Koster, Jens Bunt, Nancy E Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten-van Meeteren, Huib N Caron, Jacqueline Cloos, Alan Mrsić, Bauke Ylstra, Wieslawa Grajkowska, Wolfgang Hartmann, Torsten Pietsch, David Ellison, Steven C Clifford, Rogier Versteeg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/85a9aa46f4a043bb939c4550eb28e806 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The transcriptional landscape of Shh medulloblastoma
por: Patryk Skowron, et al.
Publicado: (2021) -
Modeling medulloblastoma in vivo and with human cerebellar organoids
por: Claudio Ballabio, et al.
Publicado: (2020) -
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma
por: Tim van Groningen, et al.
Publicado: (2019) -
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
por: Marije J. Voskamp, et al.
Publicado: (2021) -
Wnt activation as a therapeutic strategy in medulloblastoma
por: Branavan Manoranjan, et al.
Publicado: (2020)